UPS Invests $48 Million in 27 Cold-Chain Facilities as GLP-1 Drug Demand Climbs
Updated
Updated · CNBC · Jun 22
UPS Invests $48 Million in 27 Cold-Chain Facilities as GLP-1 Drug Demand Climbs
3 articles · Updated · CNBC · Jun 22
Summary
$48 million will fund 27 temperature-controlled UPS facilities across the Americas, Europe and Asia, expanding its healthcare logistics network for medicines that require tightly managed transit conditions.
UPS said the sites will improve delivery speed and end-to-end chain of custody as temperature-sensitive biologics demand is projected to grow at an 8.3% annual rate through 2033, reaching about $39.1 billion.
Cold-chain reliability has become more critical as drugs such as Novo Nordisk's Wegovy and Ozempic require strict refrigeration, while WHO data shows up to 50% of global vaccines are wasted each year, partly from storage failures.
Healthcare is already a major growth engine for UPS: the company posted its first $3 billion healthcare revenue quarter in Q1, and CEO Carol Tomé has said the business has gained market share every year since 2021.
As pharma waste hits $35B annually, is UPS's $48M investment a real solution or a symbolic gesture?
UPS is betting on AI and automation. Can technology overcome the critical shortage of skilled workers in healthcare logistics?
Is investing in fragile cold chains the best solution, or should we focus on making medicines less temperature-sensitive?
UPS Invests $48 Million to Expand Global Cold Chain Logistics: Meeting Surging Demand for Temperature-Sensitive Pharmaceuticals and Biologics
Overview
UPS is making a major investment of $48 million to build 27 new temperature-controlled facilities, expanding its global network across the Americas, Europe, and Asia. This move addresses the rising demand for specialized handling of temperature-sensitive products, especially in the healthcare sector. Reliable cold chain infrastructure is crucial for preserving the integrity and efficacy of sensitive medical products like vaccines and pharmaceuticals. With up to 50% of vaccines wasted each year due to inadequate cold-chain storage and transportation, UPS aims to reduce this waste, strengthen its healthcare division, and ensure vital products reach their destinations safely.